Team The Role of p24 Virus-Like Particles (VLPs) in HIV Research and Vaccine Development The p24 capsid protein is a crucial component of the Human Immunodeficiency Virus (HIV) responsible for the structural integrity and life cycle regulation of the virus. Virus-like particles (VLPs) con... May 30, 2024
Team Combatting Dengue Outbreaks in Brazil with AffiVLP - Flavivirus: A Technical Perspective Dengue fever remains a significant public health concern in Brazil, with recurrent outbreaks posing challenges for disease control and management. The emergence of AffiVLP - Flavivirus, a novel vaccin... Apr 3, 2024
Team Harnessing Virus-Like Particles in the Battle Against Dengue Outbreaks in Brazil Brazil, a country of diverse landscapes and rich cultural heritage, faces a persistent threat from Dengue fever outbreaks. The Dengue virus, transmitted by Aedes mosquitoes, continues to spread rapidl... Mar 18, 2024
AffiGEN Inc Exploring the Potential of Norovirus Virus-Like Particles (VLPs) Noroviruses, renowned for their role in gastroenteritis outbreaks globally, pose a persistent challenge in public health. Yet, amidst this challenge, a remarkable tool has emerged in virology: Norovir... Nov 18, 2023
AffiGEN Inc Dengue Virus VLPs: Advancements, Mechanisms, and Applications Dengue fever, a mosquito-borne viral illness caused by the Dengue virus (DENV), stands as a substantial global health concern, necessitating profound insights into its molecular intricacies for effect... Nov 18, 2023